NASDAQ:GTH

Genetron News Headlines

$20.27
+0.18 (+0.90 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.73
▼
$20.72
50-Day Range
$18.25
▼
$23.64
52-Week Range
$9.03
▼
$31.54
Volume359,775 shs
Average Volume400,597 shs
Market Capitalization$1.80 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Genetron (NASDAQ GTH) News Headlines Today

SourceHeadline
Genetron Holdings Limited (NASDAQ:GTH) Short Interest UpdateGenetron Holdings Limited (NASDAQ:GTH) Short Interest Update
americanbankingnews.com - April 17 at 2:18 AM
Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021
finance.yahoo.com - April 13 at 5:49 AM
Earnings Update: Heres Why Analysts Just Lifted Their Genetron Holdings Limited (NASDAQ:GTH) Price Target To US$26.22Earnings Update: Here's Why Analysts Just Lifted Their Genetron Holdings Limited (NASDAQ:GTH) Price Target To US$26.22
nasdaq.com - March 27 at 2:35 PM
Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22
finance.yahoo.com - March 27 at 9:35 AM
Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue GuidanceGenetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance
finance.yahoo.com - March 25 at 7:20 AM
Genetron Health Releases New Data Results of HCCscreen™ for Liver Cancer Early Screening in ChinaGenetron Health Releases New Data Results of HCCscreen™ for Liver Cancer Early Screening in China
finance.yahoo.com - March 24 at 7:24 PM
Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021
finance.yahoo.com - March 17 at 6:20 PM
Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021
finance.yahoo.com - March 4 at 6:59 PM
Genetron Healths Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in ChinaGenetron Health's Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China
benzinga.com - February 9 at 5:34 PM
Genetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in ChinaGenetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China
finance.yahoo.com - February 9 at 7:31 AM
Genetron Health to Release Thirteen Research Findings at 21st World Conference on Lung CancerGenetron Health to Release Thirteen Research Findings at 21st World Conference on Lung Cancer
finance.yahoo.com - January 27 at 7:15 AM
Stock Alert: Genetron Holdings Shares Surge 24%Stock Alert: Genetron Holdings Shares Surge 24%
markets.businessinsider.com - January 6 at 12:37 PM
Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen™ in ChinaGenetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen™ in China
finance.yahoo.com - January 6 at 7:36 AM
Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares?Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares?
finance.yahoo.com - December 20 at 10:30 AM
Where Do Hedge Funds Stand On Genetron Holdings Limited (GTH)?Where Do Hedge Funds Stand On Genetron Holdings Limited (GTH)?
finance.yahoo.com - December 12 at 12:03 AM
Genetron up 2% after HCCscreen selected by NCC, Wuxi for public health initiative in ChinaGenetron up 2% after HCCscreen selected by NCC, Wuxi for public health initiative in China
seekingalpha.com - November 27 at 3:38 PM
Genetron Says Wuxi Selects HCCscreen For Liver Cancer Screening Project - Quick FactsGenetron Says Wuxi Selects HCCscreen For Liver Cancer Screening Project - Quick Facts
nasdaq.com - November 27 at 10:37 AM
Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in ChinaGenetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China
finance.yahoo.com - November 27 at 10:37 AM
COVID-19 Highlights Role of Early Detection in Fighting Threatening Diseases, Especially Cancer, Genetron CEO Tells CNBC ConferenceCOVID-19 Highlights Role of Early Detection in Fighting Threatening Diseases, Especially Cancer, Genetron CEO Tells CNBC Conference
finance.yahoo.com - November 20 at 8:07 AM
Genetron Health Named One of the "50 Smartest Companies in China 2020" by MIT Technology ReviewGenetron Health Named One of the "50 Smartest Companies in China 2020" by MIT Technology Review
finance.yahoo.com - November 19 at 2:54 PM
Genetron Health to Present at CNBC East Tech West ConferenceGenetron Health to Present at CNBC East Tech West Conference
finance.yahoo.com - November 12 at 6:59 AM
Genetron Holdings Ltd - ADR to Host Earnings CallGenetron Holdings Ltd - ADR to Host Earnings Call
finance.yahoo.com - November 9 at 8:52 AM
Genetron Health to Present at Six Upcoming Investor and Industry ConferencesGenetron Health to Present at Six Upcoming Investor and Industry Conferences
markets.businessinsider.com - October 29 at 8:22 AM
Genetron Health to Announce Third Quarter Unaudited Financial Results and Host Investor Call on November 9, 2020Genetron Health to Announce Third Quarter Unaudited Financial Results and Host Investor Call on November 9, 2020
finance.yahoo.com - October 26 at 8:26 AM
Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic CancerGenetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer
finance.yahoo.com - October 22 at 7:46 AM
Genetron Health to Highlight Data from 18 Studies at ESMO 2020Genetron Health to Highlight Data from 18 Studies at ESMO 2020
finance.yahoo.com - September 18 at 9:52 AM
Genetron Health to Present at Upcoming Investor ConferencesGenetron Health to Present at Upcoming Investor Conferences
finance.yahoo.com - September 8 at 6:39 PM
Genetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System CancersGenetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System Cancers
finance.yahoo.com - August 29 at 2:00 PM
Genetron Health Reports Second Quarter 2020 Unaudited Financial ResultsGenetron Health Reports Second Quarter 2020 Unaudited Financial Results
finance.yahoo.com - August 6 at 10:31 AM
Genetron Health to Present at Canaccord Genuity 40th Annual Growth ConferenceGenetron Health to Present at Canaccord Genuity 40th Annual Growth Conference
finance.yahoo.com - August 6 at 4:41 AM
Genetron Health Announces Pricing of Initial Public OfferingGenetron Health Announces Pricing of Initial Public Offering
finance.yahoo.com - July 21 at 11:49 AM
Genetron Health Presents Cancer Clinical Research Data at AACR Virtual Annual Meeting Highlighting the Sensitivity and Specificity of its NGS Technology in Precision OncologyGenetron Health Presents Cancer Clinical Research Data at AACR Virtual Annual Meeting Highlighting the Sensitivity and Specificity of its NGS Technology in Precision Oncology
finance.yahoo.com - July 21 at 11:49 AM
This page was last updated on 5/6/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.